Physician profile
Gerald E Moody
NPI 1912975095
$424.60
in general payments reported to CMS, 2019-2025
13 companies · $16.79 in 2025
The $16.79 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $66.53 · 2021: $48.38 · 2022: $47.34 · 2023: $25.19 · 2024: $72.71 · 2025: $16.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $89.50 | 2024-2025 | Exparel, Iovera |
| Janssen Biotech, INC. | $57.31 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $40.28 | 2022-2023 | Abilify Maintena, Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $37.83 | 2019-2020 | |
| Getinge USA Sales, LLC | $37.56 | 2019 | |
| Abbvie INC. | $32.08 | 2019-2020 | |
| Alkermes, INC. | $29.85 | 2019-2021 | |
| Redhill Biopharma INC. | $20.71 | 2020 | |
| Shire North American Group INC | $17.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.59 | 2021 | |
| Next Science LLC | $16.30 | 2022 | |
| Vanda Pharmaceuticals INC. | $15.95 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Moody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.